Stay updated with breaking news from Zogenix inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The "Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures; By Diagnosis; By Severity; By Treatment; By. ....
Schizophrenia Pipeline Insight and Clinical Trials Analysis and NDA Approvals | 70+ Companies and 70+ Drugs virtual-strategy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virtual-strategy.com Daily Mail and Mail on Sunday newspapers.
21 scientific presentations, including 7 late breakers, showcase the breadth of UCB s portfolio, reinforcing commitment to improving the lives of people living. ....
Peer-reviewed results from the Phase 3 open-label extension study of FINTEPLA® in LGS provide significant reduction in the frequency of multiple seizure types. ....
Epilepsia Publishes Interim Results of Open-Label Extension Study of FINTEPLA® (fenfluramine) Oral Solution in Patients with Lennox-Gastaut Syndrome (LGS) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.